Carrier Frequency of the Common Mutation IVS8-1G>C in DHCR7 and Estimate of the Expected Incidence of Smith–Lemli–Opitz Syndrome

• Published in: Molecular genetics and metabolism 2001-01, Vol.72 (1), p.67-71
• Main Authors: Battaile, Kevin P., Battaile, Brian C., Merkens, Louise S., Maslen, Cheryl L., Steiner, Robert D.
• Format: Article
• Language: English
• Subjects: cholesterol; Cohort Studies; DHCR7; Gene Frequency; Genetic Testing; Heterozygote; Humans; Infant, Newborn; metabolism; Models, Genetic; Mutation; Oxidoreductases - genetics; Oxidoreductases Acting on CH-CH Group Donors; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; population; Smith-Lemli-Opitz Syndrome - genetics; Smith–Lemli–Opitz syndrome; statistics
• ISSN: 1096-7192; 1096-7206
• DOI: 10.1006/mgme.2000.3103

Smith–Lemli–Opitz syndrome (SLOS) is a multiple congenital anomaly/mental retardation syndrome of variable severity with an incidence previously estimated at 1 in 20,000–60,000 based on case frequency surveys. Identification of the gene defect in SLOS has made it possible to calculate the carrier frequency and estimate disease incidence using molecular methods to identify carriers. Using a previously described PCR-RFLP assay we screened 1503 anonymous blood samples from random newborn screening blood spot cards for the presence of the common SLOS mutation IVS8-1G>C in order to determine the carrier frequency. Sixteen carriers were identified in the 1503 samples. Since the frequency of the IVS8-1G>C mutation among all SLOS gene mutations is known, the overall carrier frequency for all mutations can be calculated. The calculated carrier frequency for all mutations based on this result is 1 in 30, predicting an SLOS incidence of 1 in 1590 to 1 in 13,500. The current incidence estimate may, therefore, significantly underestimate the true incidence of SLOS. This discrepancy between calculated and observed incidence could be due to undiagnosed mild cases, misdiagnosed severe cases, death prior to diagnosis, or fetal loss. More comprehensive incidence studies are needed to determine if SLOS is as common as predicted by the very high (1 in 30) carrier frequency determined in this study.